GenSight Biologics S.A.

GenSight Biologics S.A.verified

GSGTF

Price:

$0.1901

Market Cap:

$13.37M

GenSight Biologics S.A. is a clinical-stage biotechnology firm dedicated to pioneering, advancing, and bringing to market treatments for serious eye and central nervous system disorders, specifically those linked to mitochondrial dysfunction and neurodegeneration. Their therapeutic pipeline is built upon cutting-edge gene therapy approaches, including mitochondrial targeting sequences and optogenetics technologies. The company's primary drug candidate, LUMEVOQ (GS010), is a recombinant AAV2-based gene therapy currently undergoing Phase III clinical evaluation for Leber hereditary optic neuropathy (LHON) stemming from a specific ND4 gene mutation. Another key candidate, GS030, is in Phase I/I...[Read more]

Industry

Biotechnology

IPO Date

2018-01-22

Stock Exchange

OTC

Ticker

GSGTF

The Enterprise Value as of June 2026 (TTM) for GenSight Biologics S.A. (GSGTF) is 23.81M

According to GenSight Biologics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.81M. This represents a change of -41.64% compared to the average of 40.80M of the last 4 quarters.

GenSight Biologics S.A. (GSGTF) Historical Enterprise Value (quarterly & annually)

How has GSGTF Enterprise Value performed in the past?

The mean historical Enterprise Value of GenSight Biologics S.A. over the last ten years is 99.09M. The current 23.81M Enterprise Value has changed 2.30% with respect to the historical average. Over the past ten years (40 quarters), GSGTF's Enterprise Value was at its highest in in the June 2021 quarter at 312.21M. The Enterprise Value was at its lowest in in the December 2012 quarter at -18846.00.

Quarterly (TTM)
Annual

Average

99.09M

Median

66.79M

Minimum

25.93M

Maximum

226.96M

GenSight Biologics S.A. (GSGTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GenSight Biologics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 288.11%

Maximum Annual Enterprise Value = 226.96M

Minimum Annual Increase = -72.35%

Minimum Annual Enterprise Value = 25.93M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202525.93M-38.99%
202442.50M-2.58%
202343.63M-72.35%
2022157.80M-28.05%
2021219.32M-3.37%
2020226.96M288.11%
201958.48M-0.33%
201858.67M-29.06%
201782.71M10.43%
201674.90M20.48%

GenSight Biologics S.A. (GSGTF) Average Enterprise Value

How has GSGTF Enterprise Value performed in the past?

The current Enterprise Value of GenSight Biologics S.A. (GSGTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

37.35M

5-year avg

97.83M

10-year avg

99.09M

GenSight Biologics S.A. (GSGTF) Enterprise Value vs. Peers

How is GSGTF’s Enterprise Value compared to its peers?

GenSight Biologics S.A.’s Enterprise Value is less than Nxera Pharma Co., Ltd. (134.86B), less than MedinCell S.A. (1.04B), less than BioInvent International AB (publ) (1.16B), less than Race Oncology Limited (452.31M), less than Avacta Group Plc (330.19M), less than Basilea Pharmaceutica AG (669.74M), less than Viva Biotech Holdings (2.31B), less than Healios K.K. (21.33B), less than Allergy Therapeutics plc (394.82M), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (3.45B),

Build a custom stock screener for GenSight Biologics S.A. (GSGTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GenSight Biologics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GenSight Biologics S.A. (GSGTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GenSight Biologics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is GenSight Biologics S.A.'s Enterprise Value?

What is the highest Enterprise Value for GenSight Biologics S.A. (GSGTF)?

What is the 3-year average Enterprise Value for GenSight Biologics S.A. (GSGTF)?

What is the 5-year average Enterprise Value for GenSight Biologics S.A. (GSGTF)?

How does the current Enterprise Value for GenSight Biologics S.A. (GSGTF) compare to its historical average?